HIV-1 integrase inhibitors: a comparative review of efficacy and safety

KK Scarsi, JP Havens, AT Podany, SN Avedissian… - Drugs, 2020 - Springer
The newest class of antiretrovirals for all persons living with HIV are the integrase strand
transfer inhibitors (INSTIs). Since 2007, five INSTIs have been introduced: raltegravir …

Drug-induced hepatotoxicity

WM Lee - New England journal of medicine, 2003 - Mass Medical Soc
Drug-induced hepatic injury accounts for more than 50 percent of cases of acute liver failure
in the United States. More than 75 percent of idiosyncratic drug reactions result in liver …

Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction

RK Verbeeck - European journal of clinical pharmacology, 2008 - Springer
The liver plays a central role in the pharmacokinetics of the majority of drugs. Liver
dysfunction may not only reduce the blood/plasma clearance of drugs eliminated by hepatic …

Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis

MD Weltman, GC Farrell, P Hall… - Hepatology, 1998 - journals.lww.com
Nonalcoholic steatohepatitis (NASH) has multiple etiologic associations, but the
pathogenesis is poorly understood. Cytochrome P450 (CYP) 2E1 is induced in the liver of …

Epidemiology and individual susceptibility to adverse drug reactions affecting the liver

D Larrey - Seminars in liver disease, 2002 - thieme-connect.com
Adverse drug reactions affecting the liver represent an important challenge for safety in drug
development. Drugs can reproduce practically the whole spectrum of liver diseases, but …

Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease

CD Fisher, AJ Lickteig, LM Augustine… - Drug metabolism and …, 2009 - ASPET
Members of the cytochrome P450 (P450) enzyme families CYP1, CYP2, and CYP3 are
responsible for the metabolism of approximately 75% of all clinically relevant drugs. With the …

The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes

A Parkinson, DR Mudra, C Johnson, A Dwyer… - Toxicology and applied …, 2004 - Elsevier
We have measured cytochrome P450 (CYP) activity in nearly 150 samples of human liver
microsomes and 64 samples of cryopreserved human hepatocytes, and we have performed …

Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity

M Stockmann, JF Lock, B Riecke, K Heyne… - Annals of …, 2009 - journals.lww.com
Objective: To validate the LiMAx test, a new bedside test for the determination of maximal
liver function capacity based on 13 C-methacetin kinetics. To investigate the diagnostic …

Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence

A Elkader, B Sproule - Clinical pharmacokinetics, 2005 - Springer
Buprenorphine is a semi-synthetic opioid derived from thebaine, a naturally occurring
alkaloid of the opium poppy, Papaver somniferum. The pharmacology of buprenorphine is …

Overview of enzymes of drug metabolism

UA Meyer - Journal of pharmacokinetics and biopharmaceutics, 1996 - Springer
Most pharmacologically active molecules are lipophilic and remain un-ionized or only
partially ionized at physiological pH. Biotransformation means that a lipid-soluble xenobiotic …